Pharmacological mechanism of indigenous herb Exacum lawii on cisplatin instigated toxicity in human embryonic kidney cells (HEK-293)

Show simple item record

dc.contributor.author Sharma, Sonam
dc.date.accessioned 2024-03-27T07:09:07Z
dc.date.available 2024-03-27T07:09:07Z
dc.date.issued 2023-04-21
dc.identifier.issn 26670313
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/3027
dc.description This paper published with affiliation IIT (BHU), Varanasi in open access mode. en_US
dc.description.abstract Background: Exacum lawii C.B. Clarke (Gentianaceae) bitter medicinal herb, has been extensively applied for the treatment of kidney diseases and ailments by Indigenous medical practitioners and local communities in Maharashtra and Karnataka states of India. The pharmacognostical and phytochemical standardization has been performed, but its therapeutic mechanism is still unknown. Swertiamerin, a secoiridoid glycoside established as marker component. The aim of the current research is to investigate the cytoprotective ability and examine targets of action of Exacum lawii standardised extract against cisplatin exposed Human embryonic kidney cell line (HEK-293). Methods: Swertiamerin was isolated from standardised extract using column chromatography and characterized by various analytical techniques. In-vitro cellular assay (MTT cytotoxicity assay, iNOS expression, proinflammatory cytokine level, ROS estimation and cell cycle progression, DNA fragmentation assay and morphology of cells) were employed to understand the efficacy and mechanism of action of standardised extract and swertiamerin against cisplatin induced toxicity in HEK-293 cells. Results: Extract and swertiamerin summed up to be nontoxic to HEK-293 cells and the IC50 for cisplatin was 2.261 µg/ml. Molecular docking study showed the binding capacity of swertiamerin for iNOS enzyme (responsible for the nitrosative stress in cells). Various Scientific techniques validates the potential of extract and swertiamerin to reduce the nitrosative stress, oxidative stress, and inflammation in HEK-293 cells significantly (P < 0.05) at the dose of 50 µl (2 mg/ml) and 20 µl (0.5 mg/ml) respectively. Conclusion: This study validates the ethnomedicinal use herb Exacum lawii in nephrotoxicity. Swertiamerin as the characteristic bioactive compound might works synergistically with other phytoconstituents to prevent the cellular damage from nitrosative stress, oxidative stress, and inflammation. Therefore, present study emphasizes on the mechanism of action involved in pharmacological activity. en_US
dc.description.sponsorship Interdisciplinary School of Life Sciences and UGC-UPE, B.H.U and Department of Pharmaceutics, IIT (B.H.U) Varanasi. en_US
dc.language.iso en en_US
dc.publisher Elsevier B.V. en_US
dc.relation.ispartofseries Phytomedicine Plus;03
dc.subject Exacum lawii en_US
dc.subject HEK-293 en_US
dc.subject Nephroprotective activity en_US
dc.subject Nitrosative stress en_US
dc.subject Swertiamerin en_US
dc.subject cisplatin en_US
dc.subject Exacum lawii extract en_US
dc.subject interleukin 1beta en_US
dc.subject plant extract en_US
dc.subject reactive oxygen metabolite en_US
dc.subject swertiamarin en_US
dc.subject tumor necrosis factor en_US
dc.subject unclassified drug en_US
dc.title Pharmacological mechanism of indigenous herb Exacum lawii on cisplatin instigated toxicity in human embryonic kidney cells (HEK-293) en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search in IDR


Advanced Search

Browse

My Account